Alternative payment and care-delivery models in oncology: A systematic review Review uri icon


MeSH Major

  • Health Services Misuse
  • Neoplasms


  • Rising US health care costs have led to the creation of alternative payment and care-delivery models designed to maximize outcomes and/or minimize costs through changes in reimbursement and care delivery. The impact of these interventions in cancer care is unclear. This review was undertaken to describe the landscape of new alternative payment and care-delivery models in cancer care. In this systematic review, 22 alternative payment and/or care-delivery models in cancer care were identified. These included 6 bundled payments, 4 accountable care organizations, 9 patient-centered medical homes, and 3 other interventions. Only 12 interventions reported outcomes; the majority (n = 7; 58%) improved value, 4 had no impact, and 1 reduced value, but only initially. Heterogeneity of outcomes precluded a meta-analysis. Despite the growth in alternative payment and delivery models in cancer, there is limited evidence to evaluate their efficacy. Cancer 2018. © 2018 American Cancer Society.

publication date

  • August 2018



  • Review



  • eng

PubMed Central ID

  • PMC6110102

Digital Object Identifier (DOI)

  • 10.1002/cncr.31367

PubMed ID

  • 30141837

Additional Document Info

start page

  • 3293

end page

  • 3306


  • 124


  • 16